Phagocytosis is a critical cellular process in which cells engulf and eliminate particles larger than 0.5 μm in diameter, including microorganisms, apoptotic cells, and foreign substances.

Explore how antibody-dependent cellular phagocytosis (ADCP) targets cancer cells using monoclonal antibodies like rituximab & trastuzumab. Learn about FcγR, complement pathways, & challenges like CD47 in therapeutic efficacy.